BACKGROUND AND AIMS: Hepatitis C virus (HCV) infection is an important health problem worldwide. The aim of the study is to describe the baseline characteristics and possible epidemiological changes of the patients with chronic HCV infection included in a nationwide Greek study. PATIENTS AND METHODS: two thousand eight hundred seventeen (2817) patients, followed-up at 20 hepatology centres throughout Greece between the years 1997 and 2006 were enrolled in the study. RESULTS: Intravenous drug use (IDU) and history of blood transfusion prior to 1992 was reported in 30.7% and 22.6% of our patients, respectively. In 1865 (66.2%) patients with known genotypes, the distribution for genotype 1, 2, 3 and 4 was 45.1%, 7%, 34% and 13.9% respectively. Genotype 1 was more common in older people, in women (55.9% p<0.001) and patients with transfusion-related hepatitis (61.6% p<0.001). Genotype 3 was more common in younger patients, in men (43% p<0.001) and in IDUs (63.3% p<0.001). A significant reduction of transfusion-related hepatitis C incidence (p<0.001) in conjunction with the proportion of genotype 1 (p<0.001) was observed during the last three decades while an increase in IDU infected patients and genotype 3 was detected. CONCLUSIONS: Our study showed a significant change in HCV genotype distribution and source of HCV infection during the last three decades and under that scope, urgent actions are needed in order to control the spread of HCV infection.
BACKGROUND AND AIMS: Hepatitis C virus (HCV) infection is an important health problem worldwide. The aim of the study is to describe the baseline characteristics and possible epidemiological changes of the patients with chronic HCV infection included in a nationwide Greek study. PATIENTS AND METHODS: two thousand eight hundred seventeen (2817) patients, followed-up at 20 hepatology centres throughout Greece between the years 1997 and 2006 were enrolled in the study. RESULTS: Intravenous drug use (IDU) and history of blood transfusion prior to 1992 was reported in 30.7% and 22.6% of our patients, respectively. In 1865 (66.2%) patients with known genotypes, the distribution for genotype 1, 2, 3 and 4 was 45.1%, 7%, 34% and 13.9% respectively. Genotype 1 was more common in older people, in women (55.9% p<0.001) and patients with transfusion-related hepatitis (61.6% p<0.001). Genotype 3 was more common in younger patients, in men (43% p<0.001) and in IDUs (63.3% p<0.001). A significant reduction of transfusion-related hepatitis C incidence (p<0.001) in conjunction with the proportion of genotype 1 (p<0.001) was observed during the last three decades while an increase in IDU infectedpatients and genotype 3 was detected. CONCLUSIONS: Our study showed a significant change in HCV genotype distribution and source of HCV infection during the last three decades and under that scope, urgent actions are needed in order to control the spread of HCV infection.
Entities:
Keywords:
Greece; HCV genotypes; hepatitis C epidemiology; intravenous drug use; transfusion
Authors: C Goritsas; I Plerou; S Agaliotis; R Spinthaki; K Mimidis; D Velissaris; N Lazarou; C Labropoulou-Karatza Journal: Hepatogastroenterology Date: 2000 May-Jun
Authors: V Sypsa; G Touloumi; G V Papatheodoridis; N C Tassopoulos; I Ketikoglou; I Vafiadis; G Hatzis; D Tsantoulas; E Akriviadis; S Koutsounas; A Hatzakis Journal: J Viral Hepat Date: 2005-09 Impact factor: 3.728
Authors: M Malliori; V Sypsa; M Psichogiou; G Touloumi; A Skoutelis; N Tassopoulos; A Hatzakis; C Stefanis Journal: Addiction Date: 1998-02 Impact factor: 6.526
Authors: C A Gogos; K P Fouka; G Nikiforidis; K Avgeridis; G Sakellaropoulos; H Bassaris; A Maniatis; A Skoutelis Journal: Eur J Epidemiol Date: 2003 Impact factor: 8.082
Authors: A Katsoulidou; V Sypsa; N C Tassopoulos; J Boletis; A Karafoulidou; I Ketikoglou; D Tsantoulas; I Vafiadi; G Hatzis; A Skoutelis; E Akriviadis; T Vasiliadis; G Kitis; G Magiorkinis; A Hatzakis Journal: J Viral Hepat Date: 2006-01 Impact factor: 3.728
Authors: O Anagnostou; S Manolakopoulos; G Bakoyannis; G Papatheodoridis; A Zisouli; M Raptopoulou-Gigi; E Manesis; I Ketikoglou; G Dalekos; C Gogos; T Vassiliadis; D Tzourmakliotis; S Karatapanis; S Kanatakis; - Zoumpoulis; A Hounta; S Koutsounas; G Giannoulis; N Tassopoulos; G Touloumi Journal: Hippokratia Date: 2014-01 Impact factor: 0.471
Authors: Brittany E Yee; Nghia H Nguyen; Bing Zhang; Philip Vutien; Carrie R Wong; Glen A Lutchman; Mindie H Nguyen Journal: Eur J Gastroenterol Hepatol Date: 2014-11 Impact factor: 2.566
Authors: Lucas Wiessing; Marica Ferri; Bart Grady; Maria Kantzanou; Ida Sperle; Katelyn J Cullen; Angelos Hatzakis; Maria Prins; Peter Vickerman; Jeffrey V Lazarus; Vivian D Hope; Catharina Matheï Journal: PLoS One Date: 2014-07-28 Impact factor: 3.240
Authors: Roman Chlibek; Jan Smetana; Renata Sosovickova; Peter Gal; Petr Dite; Vlasta Stepanova; Lenka Pliskova; Stanislav Plisek Journal: PLoS One Date: 2017-04-13 Impact factor: 3.240